Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies

References

• Hidron AI, Edwards JR, Patel J, . NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 2008;29: 996–1011.
   PubMed Web of Science ®Google Scholar
• Streit JM, Jones RN, Sader HS, . Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents 2004;24: 111–118.
   PubMed Web of Science ®Google Scholar
• Gupta N, Limbago BM, Patel JB, . Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53:60–67.
   PubMed Web of Science ®Google Scholar
• Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011;17:1791–1798.
   PubMed Web of Science ®Google Scholar
• Bratu S, Mooty M, Nichani S, . Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 2005; 49:3018–3020.
   PubMed Web of Science ®Google Scholar
• Bratu S, Tolaney P, Karumudi U, . Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 2005;56:128–132.
   PubMed Web of Science ®Google Scholar
• Patel G, Huprikar S, Factor SH, . Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099–1106.
   PubMed Web of Science ®Google Scholar
• Borer A, Saidel-Odes L, Riesenberg K, . Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009;30:972–976.
   PubMed Web of Science ®Google Scholar
• Zuckerman T, Benyamini N, Sprecher H, . SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state. Bone Marrow Transplant 2011;46:1226–1230.
   PubMed Web of Science ®Google Scholar
• Klastersky J, Ameye L, Maertens J, . Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 2007;30 (Suppl. 1):S51–S59.
   PubMed Web of Science ®Google Scholar
• Bucaneve G, Micozzi A, Menichetti F, . Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 2005;353:977–987.
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA, . Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52:427–431.
   PubMed Web of Science ®Google Scholar
• Bone RC, Balk RA, Cerra FB, . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–1655.
   PubMed Web of Science ®Google Scholar
• Institute CaLS. Performance standards for antimicrobial susceptibility testing; 20th information supplement (June 2010 update). M100-S20 June 2010 Update. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.
   Google Scholar
• Anderson KF, Lonsway DR, Rasheed JK, . Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 2007;45:2723–2725.
   PubMed Web of Science ®Google Scholar
• Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. J Antimicrob Chemother 2006;57:154–155.
   PubMed Web of Science ®Google Scholar
• Costa D, Vinue L, Poeta P, . Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolates in faecal samples of broilers. Vet Microbiol 2009;138:339–344.
   PubMed Web of Science ®Google Scholar
• Poirel L, Walsh TR, Cuvillier V, . Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 2011; 70:119–123.
   PubMed Web of Science ®Google Scholar
• Chen L, Mediavilla JR, Endimiani A, . Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (blaKPC) variants. J Clin Microbiol 2011;49: 579–585.
   PubMed Web of Science ®Google Scholar
• Diancourt L, Passet V, Verhoef J, . Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005;43:4178–4182.
   PubMed Web of Science ®Google Scholar
• Kaczmarek FM, Dib-Hajj F, Shang W, . High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob Agents Chemother 2006;50:3396–3406.
   PubMed Web of Science ®Google Scholar
• Schimpff S, Satterlee W, Young VM, . Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971;284:1061–1065.
   PubMed Web of Science ®Google Scholar
• Schimpff SC, Greene WH, Young VM, . Pseudomonas septicemia: incidence, epidemiology, prevention and therapy in patients with advanced cancer. Eur J Cancer 1973;9:449–455.
   PubMed Web of Science ®Google Scholar
• Schimpff SC, Gaya H, Klastersky J, . Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. J Infect Dis 1978;137:14–29.
   Google Scholar
• Kang CI, Chung DR, Ko KS, . Risk factors for infection and treatment outcome of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy. Ann Hematol 2012;91: 115–121.
   PubMed Web of Science ®Google Scholar
• Bodey GP, Buckley M, Sathe YS, . Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328–340.
   PubMed Web of Science ®Google Scholar
• Gasink LB, Edelstein PH, Lautenbach E, . Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 2009;30:1180–1185.
   PubMed Web of Science ®Google Scholar
• Hussein K, Sprecher H, Mashiach T, . Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009;30:666–671.
   PubMed Web of Science ®Google Scholar
• Calfee D, Jenkins SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008;29:966–968.
   PubMed Web of Science ®Google Scholar
• Bulik CC, Fauntleroy KA, Jenkins SG, . Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods. J Clin Microbiol 2010;48:2402–2406.
   PubMed Web of Science ®Google Scholar
• Neonakis IK, Samonis G, Messaritakis H, . Resistance status and evolution trends of Klebsiella pneumoniae isolates in a university hospital in Greece: ineffectiveness of carbapenems and increasing resistance to colistin. Chemotherapy 2010;56:448–452.
   PubMed Web of Science ®Google Scholar
• Chen S, Hu F, Xu X, . High prevalence of KPC-2-type carbapenemase coupled with CTX-M-type extended-spectrum beta-lactamases in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China. Antimicrob Agents Chemother 2011;55:2493–2494.
   PubMed Web of Science ®Google Scholar
• Endimiani A, Hujer AM, Perez F, . Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J Antimicrob Chemother 2009;63: 427–437.
   PubMed Web of Science ®Google Scholar
• Kitchel B, Rasheed JK, Patel JB, . Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009;53:3365–3370.
   PubMed Web of Science ®Google Scholar
• Doumith M, Ellington MJ, Livermore DM, . Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 2009;63:659–667.
   PubMed Web of Science ®Google Scholar
• Park YJ, Yu JK, Park KG, . Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Diagn Microbiol Infect Dis 2011;71:87–89.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Marr KA, Park BJ, . Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010;50:1091–1100.
   PubMed Web of Science ®Google Scholar
• Hartzell JD, Neff R, Ake J, . Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin Infect Dis 2009;48:1724–1728.
   PubMed Web of Science ®Google Scholar
• Whitecar JP Jr, Luna M, Bodey GP. Pseudomonas bacteremia in patients with malignant diseases. Am J Med Sci 1970;60: 216–223.
   PubMed Web of Science ®Google Scholar
• Rello J. Pharmacokinetics, pharmacodynamics, safety and tolerability of tigecycline. J Chemother 2005;17(Suppl. 1):12–22.
   PubMed Web of Science ®Google Scholar